➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: June 7, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Apaziquone

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Apaziquone?

Apaziquone is an investigational drug.

There have been 9 clinical trials for Apaziquone. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2007.

The most common disease conditions in clinical trials are Urinary Bladder Neoplasms and [disabled in preview]. The leading clinical trial sponsors are Spectrum Pharmaceuticals, Inc, Handok Pharmaceuticals Co., Ltd., and Allergan.

Recent Clinical Trials for Apaziquone
A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Patients Undergoing TURBTSpectrum Pharmaceuticals, IncPhase 3
A Study of Intravesical Apaziquone as a Surgical Adjuvant in Patient Undergoing TURBTSpectrum Pharmaceuticals, IncPhase 3
Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)Handok Pharmaceuticals Co., Ltd.Phase 2/Phase 3

See all Apaziquone clinical trials

Clinical Trial Summary for Apaziquone

Top disease conditions for Apaziquone
Top clinical trial sponsors for Apaziquone

See all Apaziquone clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.